Clinical Research Is Hard — And It’s Only Getting Harder
It takes 7-13 years to develop a new drug
95% of physicians don’t participate in clinical trials
85% of trials miss their targeted timelines
Trials have less than 15% minority representation on average
Some studies have as high as a 30% patient dropout rate
How can we improve research to better serve patients?
Increases Access to Clinical Trials
Elligo’s adaptive engagement model — consisting of PatientSelect®, SiteSelect, Study-Level Services, Research Partner Services, and our proprietary technology portfolio — provides direct access to untapped patients, elite sites, and comprehensive research solutions.
As the ultimate healthcare-enabling research organization, we optimize the intersection of healthcare and research, maintain the integrity of the trusted patient-physician relationship, and leverage electronic health records to accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products while bringing more patients clinical research as a care option.
Challenge
It takes 7-13 years to develop a new drug
Ability to design and execute traditional, hybrid, and decentralized clinical trials
Challenge
95% of physicians don’t participate in clinical trials
Access to millions of patients and their EHR data through AI-powered analytics
Challenge
85% of trials miss their targeted timelines
End-to-end site study workflow technology
Challenge
Trials have less than 15% minority representation on average
30%+ minority representation through nontraditional patient access
Challenge
Some studies have as high as a 30% patient dropout rate
27% higher patient retention through healthcare
Challenge
It takes 7-13 years to
develop a new drug
Only Elligo offers 4x trial
acceleration
Challenge
95% of physicians don’t participate in clinical trials and 91% of patients are never invited to participate in a trial
Only Elligo has access to 150M+ patients and known physicians
Challenge
85% of trials miss their targeted timelines
Only Elligo offers end-to-end study workflow technology and support
Challenge
Trials have less than 15% minority representation on average
Only Elligo has 30%+ minority representation through non-traditional patient access
Challenge
Some studies have as high as a 30% patient dropout rate
Only Elligo has 28% higher patient retention
Customized Clinical Trial Support
PatientSelect® Increases Patient Centricity and Access to Clinical Research
Focusing on the patient healthcare journey, PatientSelect® offers direct access to known, diverse patients through HIPAA-compliant identified healthcare data, healthcare-integrated sites, proprietary technology, and AI-powered analytics.
SiteSelect Simplifies and Accelerates Trial Placement
Powered by the Study Marketplace, SiteSelect offers access to 500+ elite research sites across the U.S. in a wide range of therapeutic areas.
Study-Level Services Improve Clinical Research Site Performance
Study-Level Services support a trial’s existing sites with EHR data-driven
feasibility and protocol optimization, patient recruitment and engagement support, RecordsConnectSM medical record retrieval and processing, and patient travel to enhance overall study performance.
Research Partner Services Empower Clinical Trial Physicians
Research Partner Services provides a global clinical trial network and supportive technology, helping both new to research and experienced sites seamlessly participate in clinical trials.
Research-Enabling Technology for Clinical Data Management, Clinical Trial Enrollment, and Patient Retention
